Baird Financial Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-135,154
| Closed | -$5.85M | – | 1853 |
|
|
2021
Q2 | $5.85M | Buy |
135,154
+380
| +0.3% | +$16.5K | 0.02% | 549 |
|
|
2021
Q1 | $5.5M | Sell |
134,774
-1,526
| -1% | -$62.2K | 0.02% | 549 |
|
|
2020
Q4 | $6.17M | Sell |
136,300
-103,067
| -43% | -$4.66M | 0.02% | 489 |
|
|
2020
Q3 | $8.47M | Buy |
239,367
+4,917
| +2% | +$174K | 0.03% | 392 |
|
|
2020
Q2 | $8.85M | Buy |
234,450
+113,328
| +94% | +$4.28M | 0.03% | 370 |
|
|
2020
Q1 | $3.5M | Sell |
121,122
-55,253
| -31% | -$1.6M | 0.02% | 523 |
|
|
2019
Q4 | $9.15M | Sell |
176,375
-2,038
| -1% | -$106K | 0.03% | 392 |
|
|
2019
Q3 | $9.79M | Sell |
178,413
-868
| -0.5% | -$47.6K | 0.04% | 356 |
|
|
2019
Q2 | $7.28M | Buy |
179,281
+10,323
| +6% | +$419K | 0.03% | 422 |
|
|
2019
Q1 | $5.11M | Buy |
168,958
+158,906
| +1,581% | +$4.81M | 0.03% | 440 |
|
|
2018
Q4 | $338K | Sell |
10,052
-89,412
| -90% | -$3.01M | ﹤0.01% | 1076 |
|
|
2018
Q3 | $4.16M | Buy |
99,464
+8,949
| +10% | +$374K | 0.03% | 484 |
|
|
2018
Q2 | $2.9M | Buy |
90,515
+9,318
| +11% | +$298K | 0.02% | 561 |
|
|
2018
Q1 | $4.04M | Buy |
81,197
+32,777
| +68% | +$1.63M | 0.03% | 464 |
|
|
2017
Q4 | $2.61M | Buy |
48,420
+839
| +2% | +$45.2K | 0.02% | 550 |
|
|
2017
Q3 | $2.76M | Sell |
47,581
-416
| -0.9% | -$24.1K | 0.02% | 541 |
|
|
2017
Q2 | $2.37M | Buy |
+47,997
| New | +$2.37M | 0.02% | 563 |
|